BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9342994)

  • 21. Long-term aspirin use and mortality in women.
    Chan AT; Manson JE; Feskanich D; Stampfer MJ; Colditz GA; Fuchs CS
    Arch Intern Med; 2007 Mar; 167(6):562-72. PubMed ID: 17389287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen replacement therapy and incidence of self-reported physician-diagnosed arthritis.
    Sahyoun NR; Brett KM; Hochberg MC; Pamuk ER
    Prev Med; 1999 May; 28(5):458-64. PubMed ID: 10329335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual acuity, contrast sensitivity, and mortality in older women: Study of osteoporotic fractures.
    Pedula KL; Coleman AL; Hillier TA; Ensrud KE; Nevitt MC; Hochberg MC; Mangione CM;
    J Am Geriatr Soc; 2006 Dec; 54(12):1871-7. PubMed ID: 17198492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
    Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
    J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen replacement therapy and retinal vascular caliber.
    Wong TY; Knudtson MD; Klein BE; Klein R; Hubbard LD
    Ophthalmology; 2005 Apr; 112(4):553-8. PubMed ID: 15808243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The benefits of estrogen replacement therapy on oral health. The Leisure World cohort.
    Paganini-Hill A
    Arch Intern Med; 1995 Nov; 155(21):2325-9. PubMed ID: 7487257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.
    Grodstein F; Stampfer MJ; Falkeborn M; Naessen T; Persson I
    Epidemiology; 1999 Sep; 10(5):476-80. PubMed ID: 10468418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age at natural menopause and cause-specific mortality.
    Mondul AM; Rodriguez C; Jacobs EJ; Calle EE
    Am J Epidemiol; 2005 Dec; 162(11):1089-97. PubMed ID: 16221806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal study of estrogen and calcium supplement use among Japanese women living in Hawaii.
    Davis JW; Ross PD; Wasnich RD
    Prev Med; 1995 Mar; 24(2):159-65. PubMed ID: 7597018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does estrogen replacement therapy protect against rheumatoid arthritis?
    Spector TD; Brennan P; Harris P; Studd JW; Silman AJ
    J Rheumatol; 1991 Oct; 18(10):1473-6. PubMed ID: 1765970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health promotion and osteoporosis prevention among postmenopausal women.
    Ali NS; Twibell RK
    Prev Med; 1995 Sep; 24(5):528-34. PubMed ID: 8524729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.
    Cauley JA; Seeley DG; Ensrud K; Ettinger B; Black D; Cummings SR
    Ann Intern Med; 1995 Jan; 122(1):9-16. PubMed ID: 7985914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.